1200 ROUTE 22 EAST, BRIDGEWATER, NJ
Releases Second Quarter 2026 Financial and Operational Results
Announces Sale of Gravitas Life Sciences, LLC.
Material disclosure
Announces Authorization of Share Repurchase Program
Other Events, Press Release
Amended Sales Agreement with Clear Street and Virtu for $300M in Stock
Chairman and CEO Mark Wendland Elected to Canton Foundation Board
Announces Corporate Rebrand to Canton Strategic Holdings, Inc., Marking Milestone in Canton Network Digital Asset Treasury Strategy
Q2
Q1
FY 2025
Q3
FY 2024
Notice of Exempt Offering of Securities
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(3)
Definitive Proxy Statement
Additional Proxy Materials
PRER14A
PRE 14A
Initial Statement of Beneficial Ownership
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload